Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other produc… Read more
Dis-Chem Pharmacies (DCP) - Total Liabilities
Latest total liabilities as of August 2025: ZAC13.72 Billion ZAC
Based on the latest financial reports, Dis-Chem Pharmacies (DCP) has total liabilities worth ZAC13.72 Billion ZAC as of August 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dis-Chem Pharmacies - Total Liabilities Trend (2014–2025)
This chart illustrates how Dis-Chem Pharmacies's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dis-Chem Pharmacies Competitors by Total Liabilities
The table below lists competitors of Dis-Chem Pharmacies ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hyperion DeFi, Inc.
NASDAQ:HYPD
|
USA | $12.03 Million |
|
Cohen & Company Inc
NYSE MKT:COHN
|
USA | $672.80 Million |
|
Vanachai Group Public Company Limited
BK:VNG
|
Thailand | ฿10.39 Billion |
|
SelfWealth Limited
AU:SWF
|
Australia | AU$344.06 Million |
|
Barington/Hilco Acquisition
NASDAQ:BHAC
|
USA | $9.74 Million |
|
The Furukawa Battery Co. Ltd
F:FBB
|
Germany | €24.53 Billion |
|
Hugoton Royalty Trust
OTCQB:HGTXU
|
USA | $233.74K |
Liability Composition Analysis (2014–2025)
This chart breaks down Dis-Chem Pharmacies's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dis-Chem Pharmacies's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dis-Chem Pharmacies (2014–2025)
The table below shows the annual total liabilities of Dis-Chem Pharmacies from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-02-28 | ZAC14.03 Billion | +7.69% |
| 2024-02-29 | ZAC13.03 Billion | +12.46% |
| 2023-02-28 | ZAC11.58 Billion | +8.36% |
| 2022-02-28 | ZAC10.69 Billion | +4.43% |
| 2021-02-28 | ZAC10.24 Billion | +23.74% |
| 2020-02-29 | ZAC8.27 Billion | +22.91% |
| 2019-02-28 | ZAC6.73 Billion | +23.67% |
| 2018-02-28 | ZAC5.44 Billion | +14.18% |
| 2017-02-28 | ZAC4.77 Billion | +10.07% |
| 2016-02-29 | ZAC4.33 Billion | +94.05% |
| 2015-02-28 | ZAC2.23 Billion | +14.33% |
| 2014-02-28 | ZAC1.95 Billion | -- |